Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (61-70 of 789) with videos related to

Pageof 79
Sort By:
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Neuroscience-based Nomenclature (NbN) for Journal of PsychopharmacologyDavid J Nutt, Pierre Blier
Journal of Psychopharmacology (Oxford, England)|May 6, 2005
Gamma hydroxy butyrate abuse and dependencyAlejandro Gonzalez, David J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
Alpha-2-adrenoceptor function in alcoholicsD J Nutt, P Glue
Journal of Psychopharmacology (Oxford, England)|November 7, 2007
MDMA, politics and medical research: have we thrown the baby out with the bathwater?Ben Sessa, David J Nutt
Journal of Psychopharmacology (Oxford, England)|September 20, 2011
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?Ruth Weissenborn, David J Nutt
Journal of Psychopharmacology (Oxford, England)|January 9, 2014
Doing it by numbers: a simple approach to reducing the harms of alcoholDavid J Nutt, Jürgen Rehm
Journal of Psychopharmacology (Oxford, England)|July 12, 2011
Substitution therapy for alcoholism: time for a reappraisal?Jonathan Chick, David J Nutt
Annals of Medicine|January 1, 1990
Neuropharmacological and clinical aspects of alcohol withdrawalD J Nutt, P Glue
Journal of Psychopharmacology (Oxford, England)|January 12, 2008
Uncritical positive regard? Issues in the efficacy and safety of psychotherapyDavid J Nutt, Michael Sharpe
Neurobiology of Disease|May 21, 2013
CNS drug development in Europe--past progress and future challengesDavid J Nutt, Jim Attridge
Pageof 79

Showing results (61-70 of 789) with videos related to

Sort By:
Pageof 79
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Neuroscience-based Nomenclature (NbN) for Journal of PsychopharmacologyDavid J Nutt, Pierre Blier
Journal of Psychopharmacology (Oxford, England)|May 6, 2005
Gamma hydroxy butyrate abuse and dependencyAlejandro Gonzalez, David J Nutt
Advances in Alcohol & Substance Abuse|January 1, 1988
Alpha-2-adrenoceptor function in alcoholicsD J Nutt, P Glue
Journal of Psychopharmacology (Oxford, England)|November 7, 2007
MDMA, politics and medical research: have we thrown the baby out with the bathwater?Ben Sessa, David J Nutt
Journal of Psychopharmacology (Oxford, England)|September 20, 2011
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?Ruth Weissenborn, David J Nutt
Journal of Psychopharmacology (Oxford, England)|January 9, 2014
Doing it by numbers: a simple approach to reducing the harms of alcoholDavid J Nutt, Jürgen Rehm
Journal of Psychopharmacology (Oxford, England)|July 12, 2011
Substitution therapy for alcoholism: time for a reappraisal?Jonathan Chick, David J Nutt
Annals of Medicine|January 1, 1990
Neuropharmacological and clinical aspects of alcohol withdrawalD J Nutt, P Glue
Journal of Psychopharmacology (Oxford, England)|January 12, 2008
Uncritical positive regard? Issues in the efficacy and safety of psychotherapyDavid J Nutt, Michael Sharpe
Neurobiology of Disease|May 21, 2013
CNS drug development in Europe--past progress and future challengesDavid J Nutt, Jim Attridge
Pageof 79